Abiogen Pharma snaps up majority stake in EffRx Pharmaceuticals
EffRx Pharmaceuticals develops and commercialise prescription drugs that target musculoskeletal and rare pathologies on European and global markets…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
30 May 23
EffRx Pharmaceuticals develops and commercialise prescription drugs that target musculoskeletal and rare pathologies on European and global markets…
25 May 23
Under the terms of the transaction, Pyxis Oncology expects to issue around 4.4 million shares of its common…
24 May 23
Post-merger, the combined firm, which is expected to operate as TuHURA Biosciences and trade on Nasdaq Capital Market,…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
23 May 23
VectivBio’s lead investigational product is apraglutide, a next-generation, long-acting synthetic GLP-2 analog in phase 3, which is being…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
23 May 23
ReNAgade has developed an extensive and complementary platform that integrates its exclusive delivery technologies, such as innovative lipid…
11 May 23
The transaction, which has been unanimously approved by the Board of Directors of both the companies, is expected…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
10 May 23
The consortium comprising Elliott Investment Management, an affiliate of Elliott Associates, along with healthcare investment firm Patient Square…
10 May 23
Founded in 2021, XinThera is aiming to develop small molecule drugs for the treatment of cancer and immunologic…
09 May 23
The transaction includes BPS’ manufacturing facilities, along with around 1,700 employees working in Bloomington, Indiana and Halle, Germany,…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
01 May 23
Iveric Bio is a US-based biopharmaceutical company focused on novel therapies for ophthalmologic diseases and is currently developing…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates